bs-13175R [Primary Antibody]
FKBP10 Polyclonal Antibody
www.biossusa.com
support@biossusa.com
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: FKBP10

Immunogen Range: 50-100/582


Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 60681

Swiss Prot: Q96AY3

Source: KLH conjugated synthetic peptide derived from human FKBP10

Purification: Purified by Protein A.

Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Store at -20°C for 12 months.

Background:

The immunophilins are a highly conserved family of cis-trans peptidyl-prolyl isomerases that bind to and mediate the effects of immunosuppressive drugs, such as cyclosporin, FK506 and rapamycin. Immunophilins have also been implicated in protein folding and trafficking within the endoplasmic reticulum (ER). FKBP10 (FK506-binding protein 10), also known as peptidyl-prolyl cis-trans isomerase, PPIase, Rotamase, 65kDa FK506-binding protein or FKBP65, is a 582 amino acid immunophilin localized to the ER lumen and found in many tissues including heart, spleen, brain, testis and lung. FKBP10 contains two EF-hand calcium-binding domains and four PPIase FKBP-type domains, suggesting an enzymatic role in protein folding by catalyzing the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. FKBP10 also acts as a receptor for the immunosuppressants FK506 and rapamycin, which inhibit FKBP10 activity. FKBP10 is thought to interact with the Raf-1/HSP 90 heterocomplex during signal transduction processes, and may associate with elastin during elastin protein folding and transport. With a valine-24 addition to human FKBP10, human and mouse FKBP10 are almost identical.

Size: 100µL

Concentration: 1ug/ul

Applications: WB(1:300-5000)

Predicted Molecular Weight: 64


Cross Reactive Species: Human

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • Sun, Zhen, et al. "Identification of Chemoresistance-Related Cell Surface Glycoproteins in Leukemia Cells and Functional Validation of Candidate Glycoproteins." Journal of Proteome Research (2014).Read more>>
  • Liang L et al. Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer. Oncol Rep. 2019 Aug;42(2):615-628. Read more>>
VALIDATION IMAGES

MCF-7 Cell lysates probed with FKBP10 Polyclonal Antibody, unconjugated (bs-13175R) at 1:300 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.


293T Cell lysates probed with FKBP10 Polyclonal Antibody, unconjugated (bs-13175R) at 1:300 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.


Lane 1: Human HeLa cell lysates; Lane 2: Human LO2 cell lysates probed with FKBP10 Polyclonal Antibody, Unconjugated (bs-13175R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at room temperature for 60 min.